Jun 3, 2026
Inceptive and Alnylam announce a collaboration combining AI foundation models with RNA interference drug discovery.
The agreement links AI-generated molecular designs to pharmaceutical research. Terms include $30M upfront in cash and equity, with additional milestone payments bringing potential value to $2B.